arrow
G

Gregory L. Damhorst

Emory University
H指数:20
被引数:1,168

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Peak Nasal SARS-CoV-2 and Influenza Viral Loads Relative to Symptom Onset, 2022-2025: Impact of Vaccination and Implications for Multiplexed Testing

2022-2025年鼻咽部SARS-CoV-2和流感病毒载量峰值与症状出现时间的关系:疫苗接种的影响及对多重检测的启示

2026-04-010
PRE
Variable Staphylothrombin Activity in Staphylococcus aureus Bloodstream Infections

金黄色葡萄球菌血流感染中葡萄球菌凝血酶活性的变化

2026-02-010
PRE
Independent Testing to Accelerate the Development of Lateral Flow Assays for Influenza A, Influenza B and SARS-COV-2

独立测试以加速甲型流感、乙型流感及SARS-COV-2侧向流动检测试剂的开发

2026-01-011
PRE
Comparison of RT-PCR and antigen test sensitivity across nasopharyngeal, nares, and oropharyngeal swab, and saliva sample types during the SARS-CoV-2 omicron variant

比较SARS-CoV-2 omicron变体期间鼻咽,鼻孔和口咽拭子以及唾液样本类型的rt-pcr和抗原测试敏感性

HELIYON
IF3.6
2024-03-011
OAAI
Multisite Mpox Infection and Viral Dynamics Among Persons With HIV in Metro Atlanta
2023-11-292
OA
Investigation of Blood Plasma Viral Nucleocapsid Antigen as a Marker of Active Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection
2023-05-022
OAAI
Nucleocapsid Antigenemia in Patients Receiving Anti-CD20 Therapy With Protracted COVID-19

长期新型冠状病毒肺炎接受Anti-CD20治疗的患者的核衣壳抗原血症

2022-08-174
OAAI
Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection

核衣壳抗原血症是急性SARS-CoV-2感染的标志

2022-07-2518
OAAI
Don't forget about human factors: Lessons learned from COVID-19 point-of-care testing
2022-05-019
OAAI